Clinical Trial Update: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 1/2 study evaluating a peanut sublingual immunotherapy tablet for peanut allergy, sponsored by ALK-Abelló A/S, with t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peanut Allergy

Drugs mentioned

• Peanut SLIT-tablet (peanut extract sublingual immunotherapy tablet)

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Peanut Allergy | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING